Clinical trial NCT01783119 - References

Ulcerative Colitis — Effect of Aloe Vera in the Inflammation of Patients With Mild Ulcerative Colitis

Citation(s)

•   [Clinical guidelines for the diagnosis and treatment of chronic ulcerative colitis (CUC)
  Diagnosis. Usefulness of clinical data and laboratory analysis]. Rev Gastroenterol Mex. 2007 Jul-Sep;72(3):298-9. Spanish.
•   Atherton P
  Aloe vera revisited. British Journal of Phytotherapy 1998; 4(4): 176-183.
•   Avila H, Rivero J, Herrera F, Fraile G
  Cytotoxicity of a low molecular weight fraction from Aloe vera (Aloe barbadensis Miller) gel. Toxicon. 1997 Sep;35(9):1423-30.
•   Baumgart DC, Sandborn WJ
  Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007 May 12;369(9573):1641-57. Review.
•   Blonski W, Buchner AM, Lichtenstein GR
  Inflammatory bowel disease therapy: current state-of-the-art. Curr Opin Gastroenterol. 2011 Jul;27(4):346-57. doi: 10.1097/MOG.0b013e328347aef3. Review.
•   Bosques-Padilla FJ, Sandoval-García ER, Martínez-Vázquez MA, Garza-González E, Maldonado-Garza HJ
  [Epidemiology and clinical characteristics of ulcerative colitis in north-eastern Mexico]. Rev Gastroenterol Mex. 2011 Jan-Mar;76(1):34-8. Spanish.
•   Bottenberg MM, Wall GC, Harvey RL, Habib S
  Oral aloe vera-induced hepatitis. Ann Pharmacother. 2007 Oct;41(10):1740-3. Epub 2007 Aug 28.
•   Bousoño C, Ramos E
  Enfermedad Inflamatoria Intestinal. Bol Pediatr 46 (1): 91-99, 2006.
•   Curciarello J, De Ortúzar S, Borzi S, Bosia D
  [Severe acute hepatitis associated with intake of Aloe vera tea]. Gastroenterol Hepatol. 2008 Aug-Sep;31(7):436-8. Spanish.
•   Davis RH, Donato JJ, Hartman GM, Haas RC
  Anti-inflammatory and wound healing activity of a growth substance in Aloe vera. J Am Podiatr Med Assoc. 1994 Feb;84(2):77-81.
•   Davis RH, Leitner MG, Russo JM, et al
  Biological activity of Aloe vera. Med Sci Res ; 15: 235, 1987b.
•   El-Shemy HA, Aboul-Soud MA, Nassr-Allah AA, Aboul-Enein KM, Kabash A, Yagi A
  Antitumor properties and modulation of antioxidant enzymes' activity by Aloe vera leaf active principles isolated via supercritical carbon dioxide extraction. Curr Med Chem. 2010;17(2):129-38. Review.
•   Feagan BG, Greenberg GR, Wild G, Fedorak RN, Paré P, McDonald JW, Dubé R, Cohen A, Steinhart AH, Landau S, Aguzzi RA, Fox IH, Vandervoort MK
  Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin. N Engl J Med. 2005 Jun 16;
•   Fonseca-Camarillo GC, Villeda-Ramírez MA, Sánchez-Muñoz F, Barreto-Zúñiga R, Domínguez-López A, Uribe-Esquivel M, Yamamoto-Furusho JK
  [IL-6 and TNF-a gene expression in the rectal mucosal of patients with chronic idiopathic ulcerative colitis and control
•   Gower-Rousseau C, Salomez JL, Dupas JL, Marti R, Nuttens MC, Votte A, Lemahieu M, Lemaire B, Colombel JF, Cortot A
  Incidence of inflammatory bowel disease in northern France (1988-1990). Gut. 1994 Oct;35(10):1433-8.
•   Guo J, Xiao B, Zhang S, Liu D, Liao Y, Sun Q
  Growth inhibitory effects of gastric cancer cells with an increase in S phase and alkaline phosphatase activity repression by aloe-emodin. Cancer Biol Ther. 2007 Jan;6(1):85-8.
•   Hatano T, Kusuda M, Inada K, Ogawa TO, Shiota S, Tsuchiya T, Yoshida T
  Effects of tannins and related polyphenols on methicillin-resistant Staphylococcus aureus. Phytochemistry. 2005 Sep;66(17):2047-55. Review.
•   Holdsworth DK
  Chromones in aloe species. I. Aloesin--a C-glucosyl-7-hydroxychromone. Planta Med. 1971 Apr;19(4):322-5.
•   Kandice, LK
  Inflammatory Bowel Disease. Clinical Cornertone. Lower GI Disorders. 2002; 4(4);49-60.
•   Kim K, Kim H, Kwon J, Lee S, Kong H, Im SA, Lee YH, Lee YR, Oh ST, Jo TH, Park YI, Lee CK, Kim K
  Hypoglycemic and hypolipidemic effects of processed Aloe vera gel in a mouse model of non-insulin-dependent diabetes mellitus. Phytomedicine. 2009 Sep;16(9):856-63. doi: 10.1016/j.phymed.2009.02.014. Epub 2009 Mar 19.
•   Knigge KL
  Inflammatory bowel disease. Clin Cornerstone. 2002;4(4):49-60. Review.
•   Langmead L, Makins RJ, Rampton DS
  Anti-inflammatory effects of aloe vera gel in human colorectal mucosa in vitro. Aliment Pharmacol Ther. 2004 Mar 1;19(5):521-7.
•   León Sarabia JE, Rosales Clares V, Rosales Clares RA
  Alternativas terapéuticas para pacientes portadores de colitis idiopática utilizando aloe vera l. (sábila). Una experiencia. REV CUBANA PLANT MED.3(3):102-5,1999.
•   López-Rosés L, Olivencia-Palomar P
  Colonoscopia. Rev. esp. enferm. dig. 100(6): 372-372; 2008.
•   Mañé Almero J
  [In vivo experimental models of inflammatory bowel disease and colorectal cancer]. Nutr Hosp. 2007 Mar-Apr;22(2):178-89. Review. Spanish.
•   Martinez-Benitez, B
  Características morfológicas de la enfermedad intestinal inflamatoria idiopática. En: Yamamoto-Furusho, JK. Enfermedad Inflamatoria Intestinal: Aspectos básicos y clínicos.2010; México, D.F: Alfil
•   Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG
  Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012 Jan;142(1):46-54.e42; quiz e30. doi: 10.1053/j.gastro.2011.10.001. Epub 2011 Oct 14. Review.
•   Park MY, Kwon HJ, Sung MK
  Intestinal absorption of aloin, aloe-emodin, and aloesin; A comparative study using two in vitro absorption models. Nutr Res Pract. 2009 Spring;3(1):9-14. doi: 10.4162/nrp.2009.3.1.9. Epub 2009 Mar 31.
•   Podolsky DK
  Inflammatory bowel disease. N Engl J Med. 2002 Aug 8;347(6):417-29. Review.
•   Rabe C, Musch A, Schirmacher P, Kruis W, Hoffmann R
  Acute hepatitis induced by an Aloe vera preparation: a case report. World J Gastroenterol. 2005 Jan 14;11(2):303-4.
•   Saccù D, Bogoni P, Procida G
  Aloe exudate: characterization by reversed phase HPLC and headspace GC-MS. J Agric Food Chem. 2001 Oct;49(10):4526-30.
•   Siddharthan K
  Health insurance coverage of the immigrant elderly. Inquiry. 1991 Winter;28(4):403-12.
•   Speranza G, Morelli CF, Tubaro A, Altinier G, Durì L, Manitto P
  Aloeresin I, an anti-inflammatory 5-methylchromone from cape aloe. Planta Med. 2005 Jan;71(1):79-81.
•   Stochastic ESR analysis of rat liver and hepatoma mitochondrial lipids
  Biophys Struct Mech. 1978 Apr 13;4(2):111-4.
•   Villeda-Ramirez M
  A. Etiopatogenia de la enfermedad inflamatoria intestinal. En: Yamamoto-Furusho, JK.. Enfermedad Inflamatoria Intestinal: Aspectos básicos y clínicos. 2010; México, D.F: Alfil
•   Wild GE, Drozdowski L, Tartaglia C, Clandinin MT, Thomson AB
  Nutritional modulation of the inflammatory response in inflammatory bowel disease--from the molecular to the integrative to the clinical. World J Gastroenterol. 2007 Jan 7;13(1):1-7. Review.
•   World Healh Organization
  National policy on traditional medicine and regulation of herbal medicines .Report of a WHO global survey. Geneve 2005
•   Yamamoto-Furusho ,JK, Villalobos, JJ, Olvera, MA, Valdovinos, MA
  Colitis ulcerosa crónica inespecífica (CUCI). Gastroenterología. 59. México, Ed. Méndez. 2006; 401-4.
•   Yamamoto-Furusho JK
  Clinical epidemiology of ulcerative colitis in Mexico: a single hospital-based study in a 20-year period (1987-2006). J Clin Gastroenterol. 2009 Mar;43(3):221-4. doi: 10.1097/MCG.0b013e31817a76b4.

Effect of Aloe Vera in the Inflammation of Patients With Mild Ulcerative Colitis

Details for clinical trial NCT01783119